Prognostic role of syncytin expression in breast cancer

Human Pathology

Volumn 38, Issue 5, 2007, Pages 726-731

  Larsson, Lars Inge ^a   Holck, Susanne ^b   Christensen, Ib Jarle ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Breast cancer; Immunocytochemistry; Prognosis; Retroviral envelope protein; Syncytin

Indexed keywords

NITRIC OXIDE SYNTHASE; SYNCYTIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER CELL; CELL FUSION; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; KAPLAN MEIER METHOD; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM;

BREAST NEOPLASMS; FEMALE; GENE PRODUCTS, ENV; HUMANS; IMMUNOHISTOCHEMISTRY; PREGNANCY PROTEINS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 34147212539     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.10.018     Document Type: Article

References (28)

1. Blond J.L., Lavillette D., Cheynet V., et al. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol 74 (2000) 3321-3329
2. Frendo J.L., Olivier D., Cheynet V., et al. Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol Cell Biol 23 (2003) 3566-3574
3. Mi S., Lee X., Li X., et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403 (2000) 785-789
4. Antony J.M., van Marle G., Opii W., et al. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci 7 (2004) 1088-1095
5. Bjerregaard B., Holck S., Christensen I.J., and Larsson L.I. Syncytin is involved in breast cancer-endothelial cell fusions. Cell Mol Life Sci 63 (2006) 1906-1911
6. Mortensen K., Lichtenberg J., Thomsen P.D., and Larsson L.I. Spontaneous fusion between cancer cells and endothelial cells. Cell Mol Life Sci 61 (2004) 2125-2131
7. Miller F.R., McInerney D., Rogers C., and Miller B.E. Spontaneous fusion between metastatic mammary tumour subpopulations. J Cell Biochem 36 (1988) 129-136
8. Blond J.L., Beseme F., Duret L., et al. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol 73 (1999) 1175-1185
9. Anderson M.J., and Stanbridge E.J. Tumour suppressor genes studied by cell hybridization and chromosome transfer. FASEB J 7 (1993) 826-833
10. Harris H., Miller O.J., Klein G., Worst P., and Tachibana T. Suppression of malignancy by cell fusion. Nature 223 (1969) 363-368
11. Harris H. The analysis of malignancy by cell fusion: the position in 1988. Cancer Res 48 (1988) 3302-3306
12. Stanbridge E.J. Suppression of malignancy in human cells. Nature 260 (1976) 17-20
13. Wiener F., Klein G., and Harris H. The analysis of malignancy by cell fusion: V. Further evidence of the ability of normal diploid cells to suppress malignancy. J Cell Sci 15 (1974) 177-183
14. Mortensen K., Holck S., Christensen I.J., et al. Endothelial cell nitric oxide synthase expression in peritumoral microvessels is a favourable prognostic indicator in breast cancer. Clin Cancer Res 5 (1999) 1093-1097
15. Mortensen K., Skouv J., Hougaard D.M., and Larsson L.I. Endogenous endothelial cell nitric oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53. J Biol Chem 274 (1999) 37679-37684
16. Mortensen K., Christensen I.J., Nielsen H.J., Hansen U., and Larsson L.I. A high frequency of peritumoral microvessels expressing endothelial cell nitric oxide synthase is a favorable prognostic factor in cancer of the colon. Cancer Lett 216 (2004) 109-114
17. Qiu H., Orr F.W., Jensen D., et al. Arrest of B16 melanoma cells in the mouse pulmonary microcirculation induces endothelial nitric oxide synthase-dependent nitric oxide release that is cytotoxic to the tumor cells. Am J Pathol 162 (2003) 403-412
18. Wang H.H., McIntosh A.R., Hasinoff B.B., et al. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis. Cancer Res 60 (2000) 5862-5869
19. Larsson L.I. Immunocytochemistry. Theory and practice (1988), CRC Press, Boca Raton (Fla)
20. Pawelek J.M. Tumor-cell fusion as a source of myeloid traits in cancer. Lancet Oncol 6 (2005) 988-993
21. Tachibana I., and Hemler M.E. Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance. J Cell Biol 146 (1999) 893-904
22. Tanio Y., Yamazaki H., Kunisada T., Miyake K., and Hayashi S.I. CD9 molecule expressed on stromal cells is involved in osteoclasteogenesis. Exp Hematol 27 (1999) 853-859
23. Miyake M., Nakano K., Ieki Y., et al. Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res 55 (1995) 4127-4131
24. Hashida H., Takabayashi A., Tokuhara T., et al. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82. Int J Cancer 97 (2002) 518-525
25. Higashiyama M., Doi O., Kodama K., et al. Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis. Int J Cancer 74 (1997) 205-211
26. Funakoshi T., Tachibana I., Hoshida Y., et al. Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer. Oncogene 22 (2003) 674-687
27. Uchida S., Shimada Y., Watanabe G., et al. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer 79 (1999) 1168-1173
28. Houle C.D., Ding X.Y., Foley J.F., Afshari C.A., Barrett J.C., and Davis B.J. Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression. Gynecol Oncol 86 (2002) 69-78